Literature DB >> 31424364

Cisplatin-resistant MDA-MB-231 Cell-derived Exosomes Increase the Resistance of Recipient Cells in an Exosomal miR-423-5p-dependent Manner.

Bing Wang1, Yuzhu Zhang2, Meina Ye1, Jingjing Wu1, Lina Ma1, Hongfeng Chen1.   

Abstract

BACKGROUND: Chemoresistance blunts the therapeutic effect of cisplatin (DDP) on Triple-Negative Breast Cancer (TNBC). Researchers have not determined to date whether exosomes confer DDP resistance to other breast cancer cells or whether exosomal transfer of miRNAs derived from DDP-resistant TNBC cells confer DDP resistance.
OBJECTIVE: The aim of this study was to investigate the role of exosomes in chemoresistance in breast cancer.
METHODS: MDA-MB-231 cells resistant to DDP (231/DDP) were established. Exosomes were isolated from 231/DDP cells (DDP/EXO) and characterized by measuring the levels of protein markers, nanoparticle tracking analysis and transmission electron microscopy. MDA-MB-231, MCF-7 and SKBR-3 cell lines were treated with the isolated DDP/EXOs and cell proliferation and cytotoxicity to DDP were evaluated using MTT assays and apoptosis analyses. Western blotting was used to examine P-glycoprotein (P-gp) expression. Additionally, a microarray was used to analyse microRNA (miRNA) expression profiles in MDA-MB-231 and 231/DDP exosomes. The effects on miRNAs were determined using RT-PCR. Exosomal miR-423-5p was extracted, and differential expression was verified. The MTT cell viability assay, flow cytometry, and Transwell and immunofluorescence assays were performed to determine if differential expression of miR-423-5p sensitized cells to DDP in vitro.
RESULTS: Under a transmission electron microscope, the isolated exosomes exhibited a round or oval shape with a diameter ranging between 40 and 100 nm. DDP/EXOs labelled with PKH67 were taken up by MDA-MB-231 cells. After an incubation with DDP/EXOs, the cell lines exhibited a higher IC50 value for cisplatin, P-gp expression, migration and invasion capabilities and a lower apoptosis rate. Furthermore, 60 miRNAs from exosomes derived from 231/DDP cells were significantly up-regulated compared to exosomes from MDA-MB-231 cells. Notably, compared to the corresponding sensitive exosomes, miR-370-3p, miR-423-5p and miR-373 were the most differentially expressed miRNAs in DDP-resistant exosomes. We chose miR-423-5p, and up-regulation and down-regulation of exosomal miR-423-5p expression significantly affected DDP resistance.
CONCLUSIONS: Exosomes from DDP-resistant TNBC cells (231/DDP) altered the sensitivity of other breast cancer cells to DDP in an exosomal miR-423-5p dependent manner. Our research helps to elucidate the mechanism of DDP resistance in breast cancer. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  DDP resistance; breast cancer; cisplatin; exosomes; in vitro; miR-423-5p.

Mesh:

Substances:

Year:  2019        PMID: 31424364     DOI: 10.2174/1389200220666190819151946

Source DB:  PubMed          Journal:  Curr Drug Metab        ISSN: 1389-2002            Impact factor:   3.731


  20 in total

Review 1.  Emerging role of exosomes in cancer progression and tumor microenvironment remodeling.

Authors:  Mahshid Deldar Abad Paskeh; Maliheh Entezari; Sepideh Mirzaei; Amirhossein Zabolian; Hossein Saleki; Mohamad Javad Naghdi; Sina Sabet; Mohammad Amin Khoshbakht; Mehrdad Hashemi; Kiavash Hushmandi; Gautam Sethi; Ali Zarrabi; Alan Prem Kumar; Shing Cheng Tan; Marios Papadakis; Athanasios Alexiou; Md Asiful Islam; Ebrahim Mostafavi; Milad Ashrafizadeh
Journal:  J Hematol Oncol       Date:  2022-06-28       Impact factor: 23.168

Review 2.  The functional significance and cross-talk of non-coding RNAs in triple negative and quadruple negative breast cancer.

Authors:  Utpalendu Paul; Satarupa Banerjee
Journal:  Mol Biol Rep       Date:  2022-03-02       Impact factor: 2.742

Review 3.  Role of Exosomal miRNA in Bladder Cancer: A Promising Liquid Biopsy Biomarker.

Authors:  Xuan-Mei Piao; Eun-Jong Cha; Seok Joong Yun; Wun-Jae Kim
Journal:  Int J Mol Sci       Date:  2021-02-08       Impact factor: 5.923

Review 4.  The role of Exosomal miRNAs in cancer.

Authors:  Chuanyun Li; Tong Zhou; Jing Chen; Rong Li; Huan Chen; Shumin Luo; Dexi Chen; Cao Cai; Weihua Li
Journal:  J Transl Med       Date:  2022-01-03       Impact factor: 5.531

5.  Development of Antibody-Oligonucleotide Complexes for Targeting Exosomal MicroRNA.

Authors:  Asako Yamayoshi; Shota Oyama; Yusuke Kishimoto; Ryo Konishi; Tsuyoshi Yamamoto; Akio Kobori; Hiroshi Harada; Eishi Ashihara; Hiroshi Sugiyama; Akira Murakami
Journal:  Pharmaceutics       Date:  2020-06-12       Impact factor: 6.321

Review 6.  Role of Exosomal miRNAs and the Tumor Microenvironment in Drug Resistance.

Authors:  Patrick Santos; Fausto Almeida
Journal:  Cells       Date:  2020-06-11       Impact factor: 6.600

7.  Exosomes function as nanoparticles to transfer miR-199a-3p to reverse chemoresistance to cisplatin in hepatocellular carcinoma.

Authors:  Kun Zhang; Chu-Xiao Shao; Jin-de Zhu; Xin-Liang Lv; Chao-Yong Tu; Chuan Jiang; Min-Jie Shang
Journal:  Biosci Rep       Date:  2020-07-31       Impact factor: 3.840

Review 8.  Exosomes and breast cancer drug resistance.

Authors:  Xingli Dong; Xupeng Bai; Jie Ni; Hao Zhang; Wei Duan; Peter Graham; Yong Li
Journal:  Cell Death Dis       Date:  2020-11-17       Impact factor: 8.469

Review 9.  Functional mechanism and clinical implications of MicroRNA-423 in human cancers.

Authors:  RuiSheng Ke; LiZhi Lv; SiYu Zhang; FuXing Zhang; Yi Jiang
Journal:  Cancer Med       Date:  2020-11-11       Impact factor: 4.452

Review 10.  Tumor-Derived Extracellular Vesicles Regulate Cancer Progression in the Tumor Microenvironment.

Authors:  Qianqian Bao; Qianqian Huang; Yunna Chen; Qiang Wang; Ran Sang; Lei Wang; Ying Xie; Weidong Chen
Journal:  Front Mol Biosci       Date:  2022-01-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.